We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

205 hedge funds and large institutions have $691M invested in SANGAMO THERAPEUTICS INC in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

64% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 47

47% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $10.5M

45% more capital invested

Capital invested by funds: $476M → $691M (+$215M)

8% more funds holding

Funds holding: 190 → 205 (+15)

9.43% less ownership

Funds ownership: 64.16% → 54.73% (-9.4%)

Holders
205
Holders Change
+15
Holders Change %
+7.89%
% of All Funds
4.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
77
Reduced
47
Closed
15
Calls
$15.5M
Puts
$10.5M
Net Calls
+$4.97M
Net Calls Change
+$3.77M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$15.2M
2
Two Sigma Investments
Two Sigma Investments
New York
+$10.9M
3
BlackRock
BlackRock
New York
+$8.98M
4
GPP
Great Point Partners
Connecticut
+$8.78M
5
GLA
Great Lakes Advisors
Illinois
+$7.81M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$14.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.6M
3
Millennium Management
Millennium Management
New York
-$9.48M
4
Marshall Wace
Marshall Wace
United Kingdom
-$8.68M
5
TCM
Tang Capital Management
California
-$4.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
HighTower Advisors
101
HighTower Advisors
Illinois
$364K -$24.5K -2,642 -6%
VOYA Investment Management
102
VOYA Investment Management
Georgia
$360K -$161K -17,364 -30%
TAM
103
Tocqueville Asset Management
New York
$346K -$845K -91,115 -70%
Voloridge Investment Management
104
Voloridge Investment Management
Florida
$345K +$357K +38,454 New
ProShare Advisors
105
ProShare Advisors
Maryland
$342K +$144K +15,490 +68%
FSA
106
Franklin Street Advisors
North Carolina
$339K – – –
ECM
107
ETrade Capital Management
Virginia
$335K +$346K +37,344 New
NIT
108
NumerixS Investment Technologies
British Columbia, Canada
$331K +$342K +36,894 New
MLICM
109
Metropolitan Life Insurance Company (MetLife)
New York
$318K +$31.4K +3,388 +11%
EAM
110
Erste Asset Management
Austria
$316K – – –
D.E. Shaw & Co
111
D.E. Shaw & Co
New York
$307K +$211K +22,709 +197%
VCWA
112
Vanguard Capital Wealth Advisors
Colorado
$300K +$312K +33,580 New
Legal & General Group
113
Legal & General Group
United Kingdom
$290K +$13.4K +1,442 +5%
DCM
114
Dupont Capital Management
Delaware
$288K -$133K -14,284 -31%
VEA
115
Virtus ETF Advisers
New York
$286K -$96.4K -10,390 -25%
ACM
116
AlphaCrest Capital Management
New York
$278K +$288K +31,000 New
Ameriprise
117
Ameriprise
Minnesota
$275K +$113K +12,131 +65%
Cambridge Investment Research Advisors
118
Cambridge Investment Research Advisors
Iowa
$269K – – –
VWM
119
Vigilare Wealth Management
Arizona
$248K -$30.2K -3,250 -11%
VRS
120
Virginia Retirement Systems
Virginia
$243K +$102K +11,000 +68%
TRCT
121
Tower Research Capital (TRC)
New York
$237K +$243K +26,219 +13,110%
ASRS
122
Arizona State Retirement System
Arizona
$234K -$9.74K -1,050 -4%
Commonwealth Equity Services
123
Commonwealth Equity Services
Massachusetts
$209K +$62K +6,687 +40%
MIG
124
McGuire Investment Group
Rhode Island
$204K +$9.28K +1,000 +5%
BCV
125
Banque Cantonale Vaudoise
Switzerland
$203K +$20.2K +2,178 +11%
3 4
5
6 7

SGMO Hedge Fund Activity: Q2 2020 in Review

205 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2020, worth a combined $691M — up 45% from $476M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new SGMO positions and 15 closed out — a net gain of 16 holders — while 77 added to existing stakes and 47 trimmed.

The largest buyer was State Street, adding an estimated $15.2M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $14.7M sold.

  • 205 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2020, up from 190 in Q1 2020.
  • Funds reported $691M of SANGAMO THERAPEUTICS INC stock for Q2 2020, up 45% quarter-over-quarter.
  • 31 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2020 and 15 closed out, a net change of +16 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2020 was State Street, an estimated $15.2M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2020 was EcoR1 Capital, an estimated $14.7M sold.

Based on aggregated 13F filings for Q2 2020.